Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to begin a study into side-effects. Some cases ...

MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...

As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...